GYNECOLOGIC ONCOLOGY GROUP

说明（由申请人提供）：本申请为妇科肿瘤组（GOG） CCOP研究基地申请。GOG是一个非营利性组织，旨在促进妇科恶性肿瘤领域的临床、转化和基础科学研究。作为全球首屈一指的妇科癌症预防和治疗临床试验组，GOG已经制定了一个积极和富有成效的癌症和预防控制计划（CPC）。CPC委员会于1995年由GOG发起，已发展到46名成员，并于2005年成立了执行委员会，以更好地指导lib和III期临床试验以及观察和临床转化研究的开发，启动和完成。中共执行委员会成员包括中共委员会联合主席，nci -癌症预防部门的当然代表(dr。Minasian和Kelaghan)，预防成员(dr。Byron和Garcia)、CCOP成员（dr .、Rodriguez和Method）、实验医学和保健结果研究委员会成员以及政府统计和数据中心和行政办公室的代表。中国共产党执行委员会每年召开6次电话会议，监督中国共产党疾病现场和纪律小组委员会的工作。政府政府联盟网络主要由在正式成员机构监督下工作的社区机构组成。此外，GOG还作为31个CCOP和155个CCOP组成部分的研究基地，在许多准入非常有限的领域提供国家临床试验。CCOP领导对Method leads GOG-0224的研究方向有直接的投入。CCOPs为患者提供了途径，反过来，患者也可以获得高质量的临床试验。除了为cccop社区提供一个强有力的癌症预防和治疗研究环境外，GOG在每次会议上都提供有关高质量妇科和癌前管理的科学基础的尖端，深入的讲习班和研讨会。

DESCRIPTION (provided by applicant): This application is for the Gynecologic Oncology Group (GOG) CCOP Research Base. The GOG is a nonprofit organization promoting excellence in clinical, translational and basic scientific research in the field of gynecologic malignancies. As the premier world-wide clinical trial group in the prevention and treatment of gynecologic cancers, the GOG has developed an active and productive cancer and prevention control program (CPC). The CPC committee was initiated by the GOG in 1995 and has grown to 46 members with an Executive committee developed in 2005 to better guide the development, activation and completion of phase lib and III clinical trials and observational and clinical translational studies. The CPC Executive Committee membership includes the CPC Committee Co-Chairs, ex-officio NCI-Division of Cancer Prevention representatives (Drs. Minasian and Kelaghan), prevention members (Drs. Byron and Garcia), CCOP members (Drs, Rodriguez and Method), members of the Committees on Experimental Medicine and Healthcare Outcome Research and representatives of the GOG Statistical and Data Center and Administrative Office. Meeting by conference call six times yearly, the CPC Executive Committee oversees the work of the CPC disease-site and discipline subcommittees. The GOG affiliate network is made up of primarily community based institutions working under the supervision of a full member institution. In addition, the GOG serves as a research base for 31 CCOPs and 155 CCOP components that provide national clinical trials in many areas of very limited access. The CCOP leaders have direct input to the research directions of Method leads GOG-0224. The CCOPs provide access to patients, and patients in turn are provided access to high quality clinical trial. In addition to providing a strong environment of cancer prevention and treatment research to the CCOP community, the GOG provides, at each of its meetings, cutting edge, in depth workshops and seminars concerning the scientific underpinning for high quality gynecologic and pre cancer management.